electroCore, Inc. (ECOR)
Largest Insider Buys in Sector
ECOR Stock Price History Chart
ECOR Stock Performance
About electroCore, Inc.
electroCore, Inc., a commercial stage medical device company, engages in the development and commercialization of a range of non-invasive vagus nerve stimulation (nVNS) therapies. The company is developing gammaCore, a prescription-only nVNS therapy for the acute treatment of pain associated with migraine and episodic cluster headache in adults. Its lead product is gammaCore Sapphire, a rechargeable and reloadable handheld device for regular or intermittent use over many years. The company was incorporated in 2005 and is headquartered in Rockaway, New Jersey.
Insider Activity of electroCore, Inc.
Over the last 12 months, insiders at electroCore, Inc. have bought $484,161 and sold $0 worth of electroCore, Inc. stock.
On average, over the past 5 years, insiders at electroCore, Inc. have bought $604,002 and sold $5,960 worth of stock each year.
Highest buying activity among insiders over the last 12 months: Goldberger Daniel S (Chief Executive Officer) — $1.91M. GANDOLFO JOHN P (director) — $19,290.
The last purchase of 1,000 shares for transaction amount of $6,430 was made by GANDOLFO JOHN P (director) on 2024‑06‑13.
List of Insider Buy and Sell Transactions, electroCore, Inc.
| 2024-06-13 | GANDOLFO JOHN P | director | 1,000 0.0156% | $6.43 | $6,430 | -2.84% | ||
| 2024-06-05 | Goldberger Daniel S | Chief Executive Officer | 38,505 0.6218% | $6.43 | $247,587 | -5.28% | ||
| 2024-01-12 | POSNER BRIAN M | Chief Financial Officer | 16,000 – | $0 | $0 | +6.65% | ||
| 2023-09-15 | Goldberger Daniel S | Chief Executive Officer | 1,500 0.0246% | $5.55 | $8,333 | +8.85% | ||
| 2023-08-04 | Goldberger Daniel S | Chief Executive Officer | 50,000 – | $0 | $0 | +32.54% | ||
| 2023-08-02 | Goldberger Daniel S | Chief Executive Officer | 50,991 1.0559% | $4.35 | $221,811 | +36.88% | ||
| 2023-03-17 | Goldberger Daniel S | Chief Executive Officer | 500 0.011% | $3.43 | $1,715 | +72.64% | ||
| 2023-03-16 | Goldberger Daniel S | Chief Executive Officer | 500 0.0106% | $3.46 | $1,730 | +65.12% | ||
| 2023-03-15 | Goldberger Daniel S | Chief Executive Officer | 500 0.0108% | $3.55 | $1,775 | +63.22% | ||
| 2023-03-14 | Goldberger Daniel S | Chief Executive Officer | 500 0.011% | $3.73 | $1,865 | +58.99% | ||
| 2023-03-13 | Goldberger Daniel S | Chief Executive Officer | 500 0.0113% | $3.86 | $1,930 | +56.51% | ||
| 2022-12-14 | Goldberger Daniel S | Chief Executive Officer | 5,000 0.0071% | $0.35 | $1,749 | +2.65% | ||
| 2022-12-13 | Errico Joseph P | director | 100,000 0.1382% | $0.33 | $33,330 | +4.36% | ||
| 2022-12-13 | Goldberger Daniel S | Chief Executive Officer | 5,000 0.0068% | $0.33 | $1,649 | +4.36% | ||
| 2022-12-12 | Goldberger Daniel S | Chief Executive Officer | 5,000 0.0068% | $0.32 | $1,590 | +7.70% | ||
| 2022-12-09 | Goldberger Daniel S | Chief Executive Officer | 5,000 0.0067% | $0.30 | $1,499 | +12.38% | ||
| 2022-12-08 | Goldberger Daniel S | Chief Executive Officer | 10,000 0.0143% | $0.28 | $2,777 | +29.55% | ||
| 2022-11-29 | Errico Joseph P | director | 25,000 0.0353% | $0.33 | $8,253 | +6.31% | ||
| 2022-11-25 | Errico Joseph P | director | 50,000 0.0678% | $0.31 | $15,735 | +7.03% | ||
| 2022-11-23 | Errico Joseph P | director | 100,000 0.1459% | $0.31 | $31,050 | +16.67% |
Insider Historical Profitability
| Goldberger Daniel S | Chief Executive Officer | 249565 2.2668% | $6.32 | 18 | 0 | +21.16% |
| POSNER BRIAN M | Chief Financial Officer | 22437 0.3738% | $6.32 | 4 | 1 | <0.0001% |
| GANDOLFO JOHN P | 50704 0.3165% | $6.32 | 3 | 0 | <0.0001% | |
| Merck Global Health Innovation Fund, LLC | 10 percent owner | 3346032 55.7447% | $6.32 | 1 | 0 | |
| Errico Joseph P | director | 2724841 45.3957% | $6.32 | 10 | 6 | +13.07% |
| TULLIS JAMES L L | director | 1764705 29.3999% | $6.32 | 3 | 0 | +23.04% |
| Errico Thomas J. | director | 1526700 25.4347% | $6.32 | 9 | 0 | +0.36% |
| Moody Trevor J | 423455 7.0547% | $6.32 | 3 | 0 | +16.3% | |
| Amato Francis R. | Chief Executive Officer | 358831 5.9781% | $6.32 | 1 | 0 | <0.0001% |
| Staats Peter S. | Chief Medical Officer | 154636 2.5762% | $6.32 | 1 | 0 | <0.0001% |
| COX CARRIE SMITH | director | 21000 0.3499% | $6.32 | 3 | 0 | <0.0001% |
Institutional Investor Ownership
No records found… | |||||||